脂质纳米颗粒的进步为固体癌症提供遗传药物
Fan Yang1,2, Tristan A Scott1,2
1Beckman Research Institute and Hematological Malignancy and Stem Cell Transplantation Institute at the City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
Molecular therapy. Nucleic acids
|February 16, 2026
概括
脂质纳米粒子 (LNP) 技术为固体瘤提供基因药物提供了进步. 临床瘤治疗提供了多功能策略,可以直接向瘤或调节免疫微环境,以加强癌症治疗.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 固体瘤由于其复杂的瘤微环境 (TME) 给核酸输送带来了重大挑战.
- 脂质纳米颗粒 (LNP) 已经成为将遗传药物输送到固体瘤的关键技术.
- TME经常充当障碍物,阻碍治疗性核酸的有效输送.
研究的目的:
- 审查LNP技术的最新进展,以向固体瘤输送遗传药物.
- 讨论基于LNP的癌症治疗方法的挑战和未来前景.
- 探索针对癌细胞,瘤血管和免疫微环境的多种LNP输送策略.
主要方法:
- 关于LNP技术和在瘤学中提供遗传医学的当前文献的综述.
- 对LNP能力的分析,包括局部/系统管理和通过连接体结合的有针对性的输送.
- 检查LNP提供的各种遗传医学模式 (例如,小型非编码RNA,毒素基因,免疫调节剂).
主要成果:
- 通过将基因有效载荷直接传递给癌细胞或通过免疫调节间接传递给癌细胞,LNP能够产生多种不同的抗癌作用.
- 向策略包括直接抑制致癌途径,破坏瘤血管结构,增强抗瘤免疫力.
- 随着LNP的多功能性,可以进行量身定制的治疗方法,解决特定的瘤特征和微观环境.
结论:
- 对于开发针对固体瘤的新型瘤疗法,LNP技术具有显著的前景.
- 克服TME障碍和优化LNP交付仍然是关键的挑战.
- 对LNP设计和遗传医学有效载荷的持续研究将扩大它们在癌症治疗中的治疗潜力.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
17
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
17
01:29Pharmacogenomics: Identification of New Drug Targets
9
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9
01:24Modified-Release Drug Delivery Systems: Site-Targeted
18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K